12 May 2021
PRESS RELEASE
European Federation of Pharmaceutical Industries and Associations（EFPIA Japan）

EFPIA Japan Patient Organization Support Program “PASE”
Call for entries for the fourth PASE AWARDS~ Theme: Addressing the challenges of the COVID-19 pandemic and encouraging
connected, supportive societies ~European Federation of Pharmaceutical Industries and Associations (EFPIA Japan) is pleased toannounce that the fourth PASE AWARDS will be implemented as part of its patient advocacy program,
PASE (Patient Advocacy Support by EFPIA Japan). This year’s theme is "addressing the challenges of theCOVID-19 pandemic and creating connected, supportive societies.” EFPIA Japan now welcomes entries
from patient groups and will provide a grant of ¥500,000 as a Grand Prize (up to two winning organizations)and ¥150,000 as an Honor Award (up to three winning organizations).
Since last year, COVID-19 has imposed numerous limitations in daily life, causing a heightened sense ofloneliness for many patients. To enhance understanding and empathy in this environment, it has become
more important than ever before to create strong connections between patients and society and establish
good communication between patients and their doctors.
This year for the fourth PASE AWARDS, entries are being solicited from patient advocacy groups that have
utilized online tools, SNS and other channels to provide necessary information on ways to prevent,diagnose, treat and control the novel coronavirus infection as well as support communication between
physicians and their patients. In addition, entries are being called from patient advocacy groups that areworking to realize healthcare policies that reflect patient needs. (Peer support activities, talk gatheringsand other similar activities are not eligible).
EFPIA Japan promotes patient advocacy activities in Japan and supports the development of a bettermedical environment for patients by working to reflect the voices of patients in the healthcare system.

EFPIA Japan
ThinkPark Tower, 2-1-1, Osaki, Shinagawa-ku, Tokyo 141-6017
Tel: +81-3-6417-2032

Fax: +81-3-6685-4870

Fourth PASE AWARD Application Guidelines◼

Theme: Addressing the challenges of the COVID-19 pandemic and creating connected,
supportive societies
EFPIA Japan is soliciting activity plans aimed to prevent social isolation among patients and tocreate a society where everyone can receive appropriate healthcare. Examples include activities
that utilize SNS and other channels to provide information or support better communication
between patients and their physicians, efforts that enhance societal awareness, initiatives thatcreate better healthcare policies, and other activities that broadly support patients and the people
around them. (Peer support activities, talk gatherings and other similar activities are not eligible).

◼

Application guidelines
1. Qualification requirements:
1. A patient group working for patients in Japan
2. An officially registered non-profit organization, such as an incorporated association,foundation, NPO, etc.
3. A patient group with a clear mission
4. A concrete implementation plan for an activity utilizing the grant (including how the grant willbe used)
5. A willingness to disseminate the results of the activity utilizing the grant (permission to poston EFPIA Japan’s website, notification and reporting on the patient advocacy group’s own
and other websites).
2.

Requirements for award-winning organizations:
1. Attend the online presentation award ceremony on EFPIA Day (scheduled to be held in
September 2021. There may be media coverage and schedule changes.)
2. Conduct activities using the grant by the end of June 2022
3. Submit an activity report (two A4 pages) to the EFPIA Japan Secretariat by the end ofOctober 2022

3.

Use of Grants:
The financial award should be used for projects with clear implementation plans. It cannot beused to provide cash to individuals or to supplement the working capital of a group.

4.

Application method:
Please write the items listed below on the application form (no prescribed format) and send it tothe EFPIA Japan PASE AWARD Secretariat (pase-award@cocoknots.co.jp) as a PDF file by July2, 2021.

5.

Contact:
Ms. Ikemori or Ms. Ishiyama
EFPIA Japan PASE AWARD Secretariat (c/o CocoKnots)
TEL: 03-5213-4410
E-mail: pase-award@cocoknots.co.jp

EFPIA Japan
ThinkPark Tower, 2-1-1, Osaki, Shinagawa-ku, Tokyo 141-6017
Tel: +81-3-6417-2032

Fax: +81-3-6685-4870

◼

Items to be included on the application form
1. Information about the organization
1. Name of the organization (English and Japanese)
2. Website URL
3. Name of person in charge (e-mail address and telephone number)
4. List of board members
5. Articles of incorporation
6. Copy of the register or copy of the webpage where the register is indicated on a governmentor government-commissioned organization website (see below)
NPO: https://www.npo-homepage.go.jp/npoportal/
Public interest corporation: https://www.koeki-info.go.jp/outline/index.html
General incorporated foundation or general incorporated association: http://www.disclokoeki.org/kensk/index.html
7. Copy of the previous year’s income and expenditure report
2.

Short essay (about 1,500 letters, describing the following two points):
1. Past activities of the organization and concrete achievements (that show dedication andcontribution to patients)
2. Purpose and implementation plan of activities using the grant (including how the grant will beused)◼

Selection method
1. Based on the content of the essays, the EFPIA Japan Access Committee will select the top fiveorganizations.
2. The top five organizations will attend the final selection meeting, scheduled to be held online at
the end of August, and will give a presentation (based on the content of the short essay)* to theEFPIA Japan final selection jury members.
*The presentation time is five minutes and up to three PowerPoint slides may be used. Thepresentation can be conducted in Japanese or English. There will be a five-minute Q&A with thefinalists for a total of 10 minutes per patient group.
3. The impact of the proposed activities on society and patients' lives, the enthusiasm for theproposed activities, and the presentation and answers to questions from the EFPIA members(clarity of points, time management, comprehension, etc.) will be considered, and up to twogroups will be selected as winners of the Grand Prize. The Grand Prize may be awarded to agroup up to two consecutive times. For the Honor Award, up to three groups will be selected.
4. Up to two selected organizations will attend the online EFPIA Day Award Ceremony and give themedia the presentation they gave at the final selection meeting.

◼

Procedure after the award
1. Notification of results:
Award-winning organizations will be notified directly by September 3, 2021, and their names will
be posted on the EFPIA Japan website at a later date.
2. Award grants:
Money will be transferred through a financial institution account transfer.

EFPIA JapanThinkPark Tower, 2-1-1, Osaki, Shinagawa-ku, Tokyo 141-6017
Tel: +81-3-6417-2032

Fax: +81-3-6685-4870

About the EFPIA Japan Patient Organization Support Program “PASE”
EFPIA Japan works with patients to support opportunities and activities that address patient needs andpolicy proposals. PASE (Patient Advocacy Support by EFPIA Japan) is a patient organization support
program established with the goal of realizing EFPIA Japan’s patient-focused thinking. PASE wasconceived to further encourage patient group activities in Japan and to support the development of ahealthcare environment that better reflects patient needs.
About the PASE AWARD
EFPIA Japan created the PASE AWARDS in 2017 as a means to more directly carry out its patient-centricmission to support patient organizations and promote the development of patient advocacy in Japan. For
the third PASE AWARDS held in 2019, selection was based on four evaluation criteria: 1) a patient groupwith a clear mission and performance indicators; 2) past activities with concrete results that achieve thestated goals; 3) a specific implementation plan for an activity utilizing the grant; and 4) a willingness todisseminate the results of the activity utilizing the grant (permission to post on EFPIA Japan’s website,
notification and reporting on the patient advocacy group’s own and other websites). Among 15organizations, two were selected for the Grand Prize and three were selected for the Honor Award toreceive a total of 1.45 million yen in grants. For further details, please refer to the link below.
190902_PASE_ResultAnnouncement_ENG_Final.pdf (efpia.jp)
About the European Federation of Pharmaceutical Industries and Associations (EFPIA) Japan(http://efpia.jp/)
EFPIA Japan, established in April 2002, represents 20 European R&D-based pharmaceutical companies
operating in the Japanese market. Combined 2019 sales of EFPIA member companies account for
approximately 23% of the pharmaceutical market in Japan. The mission of EFPIA Japan is to “contributeto healthcare and patients in Japan through the rapid introduction of innovative medicines and vaccines.”
EFPIA Japan aims to strengthen communication with policymakers for the improvement of Japanese
healthcare.
Inquiries:
Jun Saito
EFPIA Japan Public Relations Committee, person
in charge of PASE
Novartis Pharma K.K.
Toranomon Hills Mori tower
1-23-1 Toranomon, Minato-ku, Tokyo 105-6333
TEL: 080-7566-8852
E-mail:jun.saito@novartis.com

Naomi Sakai
EFPIA Japan Patient Committee, person incharge of PASE
Nippon Boehringer Ingelheim Co., Ltd.
ThinkPark Tower
2-1-1 Osaki, Shinagawa-ku, Tokyo 141-6017
TEL: 03-6417-2489
E-mail: naomi.sakai@boehringer-ingelheim.com

EFPIA Japan
ThinkPark Tower, 2-1-1, Osaki, Shinagawa-ku, Tokyo 141-6017
Tel: +81-3-6417-2032

Fax: +81-3-6685-4870